Bristol Myers Squibb
I have over 20 years of industry experience in applications of mass spectrometry. If elected to the board of Directors, I will seek to advance ASMS initiatives including publication strategies with the aim to enhance interactions and collaborations between academic and government researchers with industry scientists.
Guodong Chen, B.S. in Chemistry (University of Science and Technology of China); M.S. in Analytical Chemistry (West Virginia University with Professor Fred King); Ph.D. in Analytical Chemistry (Purdue University with Professor Graham Cooks). Dr. Chen has over 20 years of experience in the pharmaceutical industry, working at Eli Lilly, Schering-Plough and Bristol Myers Squibb with increasing responsibility. He is currently a Research Fellow at Bristol Myers Squibb in New Jersey.
Dr. Chen’s research interests include development and applications of mass spectrometry in drug discovery and development through internal efforts and global collaborations with academic and industrial partners. He has led the establishment of innovative industry-leading analytical capabilities for characterization and assay development for drug targets and therapeutic modalities including small molecules, peptides, biologics and novel modalities. His research efforts have emphasized higher order structure characterization, biophysical characterization, protein/drug interactions, epitope mapping and in vitro/in vivo liability assessment for drug candidate molecules. His work has resulted in over 90 peer-reviewed publications and book chapters. He has edited/co-edited three books on mass spectrometry: “Characterization of Protein Therapeutics Using Mass Spectrometry” (Springer), “Protein and Peptide Mass Spectrometry in Drug Discovery” (Wiley), and “Characterization of Impurities and Degradants Using Mass Spectrometry” (Wiley). He holds more than 30 U.S. patents (issued/pending).
Dr. Chen has organized and chaired sessions at scientific forums, including ASMS, ACS, Pittcon, EAS, CPSA and HOS. He has served as Program Chair for 2016 ASMS Sanibel Conference and on two ASMS Award selection committees. He has been coordinator of the ASMS Biotherapeutics Interest Group and Chair for North Jersey Mass Spectrometry Discussion Group. He has taught short courses on mass spectrometry at ASMS, Pittcon and EAS. Currently, Dr. Chen is on the Board of Associate Directors for CASSS and is a member of the Organizing Committee for International Symposium on Higher Order Structure of Protein Therapeutics. He is also on the Editorial Board of JASMS.